MARCKS Antibodies

Santa Cruz Biotechnology features a diverse variety of MARCKS Antibodies for research focused on understanding Myristoylated Alanine-Rich C Kinase Substrate (MARCKS). MARCKS Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) plays essential roles in cellular signaling and cytoskeletal dynamics. MARCKS influences cell motility, growth, and differentiation processes, making it a significant focus in cancer and neurodegenerative disease research. Research has shown that MARCKS expression levels can vary significantly in different pathological conditions. Understanding MARCKS activity and regulation provides valuable insights into cellular mechanisms and disease progression. Investigating MARCKS functions helps identify potential therapeutic targets for various medical conditions. Current research continues to uncover new roles for MARCKS in cell signaling pathways and disease development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of MARCKS and its impact on human health.